source
- Nominations Open for 2026 Endpoints 11 Biotech AwardsNominations for the 2026 Endpoints 11 awards are now being accepted, with submissions due by July 15. The awards target private biotech startups that have differentiated science, strong leadership…
- Unicycive gets second CRL for kidney drug as manufacturing woes continueUnicycive Therapeutics’ chronic kidney disease drug was rejected by the FDA for a second time over persistent issues at a third-party contract manufacturer. The company’s phosphate binder drug oxyl…Endpoints · 1mo ago↗ source
- Sanofi’s Lumizyme successor passes Phase 3 test in babies with Pompe disease